For the treatment of unilateral laryngeal paralysis with glottic insufficie
ncy injection laryngoplasty is a popular modality of treatment. This proced
ure augments the volume of the paralyzed vocal fold by endoscopic injection
. However, the ideal substance has not yet been found for that purpose, We
report for the first time the systematic application and long-term results
of vulcanized polydimethylsiloxane (PDMS) particles in the treatment of glo
ttic insufficiency in the human larynx. Of 10 patients treated with PDMS in
the early 1990s, 7 patients could be retrieved for reevaluation. Laryngeal
function was assessed by videostroboscopy, expert rating, and further char
acterized by the objective parameters of voice profile and maximum phonatio
n time, In a standardized questionnaire, all patients were asked for their
personal impression of the results. Mean follow-up time was 88.4 months (ra
nge 69-102 months). Glottic closure was complete in 5 of 7 patients, There
were no signs of granuloma formation or of her pathologic changes of the in
jected vocal folds. In 4 cases, voices were rated normal or near-normal; 2
voices were rated as fair; 1 usable. All the patients reported significant
and lasting voice improvement. None of the patients reported any problems r
elated to PDMS. PDMS particles provide permanent augmentation of human voca
l fold volume without complications. Their use is a valuable and safe alter
native when a definitive one-step procedure seems advantageous, However, fu
rther studies are needed to assess voice improvement in comparison to other
materials (C) 2000 John Wiley Be Sons, Inc.